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Background

Materials and Methods
•	Study type:

		– R
 etrospective, hypothesis-generating study conducted at a large, tertiary, single center
teaching hospital for 6 months.

•	Equipment and Endoscopic Ultrasound (EUS) Procedure:

		– Patients monitored under anesthesia care with procedures performed using a linear array

•	Sharkcore Fine Needle Biopsy (FNB)
system allows for interchangeability
of all needle sizes through a
universal delivery system for rapid
needle exchange and passes
and for the possible collection of
histological samples.
•	Studies suggest that diagnostic
accuracy/adequacy can be
enhanced with the use of rapid
onsite evaluation (ROSE).
•	Advantage of FNB vs FNA
		– A
 ccurate diagnosis of an
otherwise undifferentiated tumor
with tissue acquisition
		– Options involving surgical and
oncologic care can be guided by
the results
		– Prevent inappropriate treatment

echoendoscope in left lateral decubitus position. EUS guided FNB was done with the 22G and 25G
FNB needle of stainless steel (ID 0.020”, 0.014 “and OD 0.028” and 0.020”), respectively.
		– L
 ocalization of mass followed by needle puncture, stylet removed, and needle moved to-and-fro
within the lesion four times. All tissue sampling performed with slow pull technique.4 Specimen then
expressed onto slides by flushing air into needle assembly.

•	Sampling Process:
		– S
 ample is obtained from needle onto two slides, one for Diff Quick staining, one Papanicolaou stain.

				• If core biopsy present, tissue material placed into a formalin container.

		– S
 amples that not evaluated with ROSE were collected and sent directly to the pathology

department.
				• Initial adequacy during ROSE determined by cytotechnologist and final adequacy verified by
final pathology report.
				• Adequacy based on cells appearing to be malignant or a different architecture compared to
normal tissue.
		– A
 ll biopsy needles are rinsed in CytoLyt.
				• If thick tissue fragments present, cell block for histological processing was created.

•	Assess the adequacy of tissue
samples obtained from the
SharkCore FNB
•	Determine if location of the mass/
lesion effects adequacy
•	Assess if ROSE is necessary in
assisting with adequacy
•	Determine if the SharkCore FNB
system can produce core tissue
specimens for histological sampling

• Adequacy of samples determined by final pathological read was 87.9%.

Table 2. Clinical Characteristics of Patients
Variable

		– F
 actors to increase adequacy in sampling are ROSE availability, experience of the endosonographer and

Patients (n=33)

Average Age +SD, yrs

familiarity or continued exposure to EUS procedures.5-7

63.3 ± 16.8

•	Our study indicated, based on the pathology protocol, that this needle system did not provide core
tissue samples.

Sex
• Male
• Female

16 (48.5%)
17 (51.5%)

Race/ethnicity
• Caucasian
• African American
• Other

29 (87.9%)
1 (3.0%)
3 (9.1%)

Location of mass*
• Pancreas
–H
 ead
–B
 ody
–T
 ail
• Intra-abdominal lymph node
• Hepatic
• Gastric/Submucosa
• Biliary

19 (57.6%)
8 (24.2%)
9 (27.3%)
2 (6.1%)
6 (18.2%)
2 (6.1%)
4 (12.1%)
2 (6.1%)

•	ROSE allows real time feedback to endosonographers to assist in adequacy samples for biological
sampling with about a 10-15% increase in specimen yield in at least solid pancreatic masses.3

3 (9.1%)
29 (87.9%)
1 (3.0%)

		– M
 ajority of cases were sampled from pancreas with an adequacy rate of 84.2%.
		– Intra-abdominal lymph nodes, hepatic masses and biliary samples had 100% adequacy rate but were a

FNB Adequacy
• Inadequate
• Adequate
• Less than optimal/inconclusive
FNB Results
• Benign/Non-malignant
• Malignant
• Inconclusive

		– M
 ajority of samples underwent histological processing, but were done so as an afterthought.
		– O
 ne study reviewed the use of both FNA and FNB systems to obtain histological samples and revealed
the FNB to be unsatisfactory in yielding core specimen compared to the FNA system.8

		– 9
 6.2% of cases were able to obtain adequate sample, but with ROSE absent, a majority of cases were
still found to have adequate samples.

•	Adequacy based on location of mass
low sample size
		– O
 ur study is different in that it evaluates many different pathological sites not limited to solid pancreatic
masses that are showing adequate sampling with the use of the SharkCore FNB system.

12 (36.4%)
16 (48.5%)
5 (15.2%)

* Some percentages may not equal 100% due to rounding.

•	Statistical analysis:

		– T
 he analysis was purely descriptive and exploratory in nature with descriptive statistics presented for
the entire sample as a whole.
		– M
 eans presented with the standard deviation for the continuous variables (age)
		– P
 ercentages given for all cases that resulted in an adequate tissue sample overall and broken down
by location of the mass.
Table 1. FNB Background

Study Aims

Discussion

Results

Indications for FNB 1 Contraindications 1
• P ancreatic mass
• Cystic lesion with solid
components
• Mediastinal lymph node
and/or mass
• Retroperitoneal lymph
node and/or mass
• Perirectal lymph node
and/or mass
• Lesion(s) in the left liver
lobe
• Left adrenal mass
• Intestinal/gastric
Subepithelial mass/lesion

• S evere
thrombocytopenia
• Severe coagulopathies
• Inability to properly
visualize lesion/mass

Complications 2-3
• P ancreatitis
• Post procedure
hypotension
• Seizure
• Laryngospasm
• Post procedural
abdominal pain

Study Inclusion Criteria

Exclusion Criteria

Age > 18 years old

Untreated coagulopathy

Pancreatic, hepatic, gastric, intra-abdominal or mediastinal
mass seen on prior imaging (CT, MRI or EGD)

Active pancreatitis

Masses/lesions were accessible with 19g, 22g or 25g needle

Biopsies performed utilizing a
different FNA system

Mass/lesion composed of some solid components
EUS-FNB performed by one of two advanced
endosonographers

Mass/lesion felt not to be safely
accessible

Table 3. ROSE EUS-FNB Adequacy Compared with Non ROSE EUS-FNB

FNB Adequacy

ROSE Absent

Adequate

25 (96.2%)

4 (57.1%)

Inadequate

1 (3.8%)

2 (28.6%)

Less than optimal

0 (0.0%)

1 (14.3%)

26

7

Total Patients (n)
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FNB Adequacy
Location of Mass Adequate

Inadequate

•	Small sample size (n = 33), single center
•	Short time period (6 months) for both
advanced endosonographers to access and
train with new FNB system
•	Pathology protocol for core tissue biopsies
References:

Table 4. Adequacy Based on Location of Mass
Less than
Optimal

Total Patients
(n)

16 (84.2%)
7 (87.5%)
8 (88.9%)
1 (50.0%)

2 (10.5%)
0 (0.0%)
1 (11.1%)
1 (50.0%)

1 (5.3%)
1 (12.5%)
0 (0.0%)
0 (0.0%)

19

6 (100%)

0 (0.0%)

0 (0.0%)

6

Hepatic

2 (100%)

0 (0.0%)

0 (0.0%)

2

Gastric/Submucosa

3 (75.0%)

1 (25.0%)

0 (0.0%)

4

Biliary

2 (100%)

0 (0.0%)

0 (0.0%)

2

Pancreatic
• Head
• Body
• Tail
Intra-abdominal
Lymph Node

Figure 1. Shark Core fine needle biopsy system with 6 beveled cutting edge surface to
decrease tissue fracturing and penetration force while maintaining intact tissue structure.

ROSE Present

Limitations
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Future Studies
•	Utilizing this technology for intra-thoracic
malignancy
•	Comparing ROSE adequacy with final pathology
•	If increase familiarity with the system decreases
the need for ROSE
•	Change in how samples are processed by
pathology
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